Stelis Biopharma appoints Mark W. Womack as CEO Stelis Biopharma appoints Mark W. Womack as CEO Before joining Stelis, Womack was the Chief Business Officer for AGC Biologics Boyden appoints life sciences expert as Managing Partner, Japan Boyden appoints life sciences expert as Managing Partner, Japan Irish was formerly Regional Practice Head, Asia/Pacific, Healthcare & Life Sciences at a global executive search firm based in Japan Bürkert appoints Account Manager for Scotland Bürkert appoints Account Manager for Scotland The company’s previous Account Manager for Scotland, Craig Kerr, has been appointed UK Sales Manager Guy Goodwin joins Compass Pathways as CMO Guy Goodwin joins Compass Pathways as CMO Goodwin is Emeritus Professor of Psychiatry at The University of Oxford. He was formerly WA Handley Chair of Psychiatry and head of the university’s Department of Psychiatry Median Technologies appoints CFO to executive committee Median Technologies appoints CFO to executive committee Montigny joins Median Technologies with more than 25 years of management committee experience Sterling Pharma Solutions appoints flow chemistry team lead Sterling Pharma Solutions appoints flow chemistry team lead Professor Baxendale is currently Chair of Synthetic Chemistry within the Department of Chemistry at Durham University Metrion Biosciences appoints CCO and Head of Global Business Development Metrion Biosciences appoints CCO and Head of Global Business Development Nick Foster has held positions at Charles River Laboratories, Optibrium Limited and WuXi AppTec SPT Labtech announces leadership team changes SPT Labtech announces leadership team changes Patrick Bennett, the former Group CEO, will assume the role of Chair of the board and continue to work with the wider team in executing the company’s commercial strategy DeepMatter appointments Non-Executive Director DeepMatter appointments Non-Executive Director The company will seek to leverage his knowledge to further develop its data platforms and ensure they meet the needs of the pharmaceutical industry Surfachem restructures its business unit Surfachem restructures its business unit Ori Biotech appoints senior management roles Ori Biotech appoints senior management roles Stuart Milne and Kevin Gordon will join the company as CTO and Chief Data & Operating Officer respectively Ilya Pharma strengthens senior management Ilya Pharma strengthens senior management Pfizer veteran Sylvia McBrinn joins Board while Oskar Lund becomes CFO ACG appoints two senior Design Heads ACG appoints two senior Design Heads Both join the company’s R&D facility in Germany Stablepharma announces addition to advisory board Stablepharma announces addition to advisory board The company’s patented StablevaX technology is designed to thermally stabilise and deliver vaccines without the requirement for refrigeration Peli BioThermal appoints VP of Global Services Peli BioThermal appoints VP of Global Services Since joining the Peli BioThermal team, Hyde has expanded the company’s Crēdo on Demand rental program by growing global drop points, service centres and network stations BioAscent appoints two Associate Directors BioAscent appoints two Associate Directors Dr Angelo Pugliese and Dr McArthur will be working as Associate Director of in silico discovery and data analysis, and Associate Director of medicinal chemistry respectively